# Contact Wolverine Meds | BPC-157 TB-500 Editorial

> Contact Wolverine Meds, the independent editorial BPC-157 TB-500 research console. Editorial correspondence only — not a clinic, not a vendor, and not a source for medical or purchasing advice.

Corrections, citation questions, and editorial correspondence about the BPC-157 TB-500 record are welcome here.

## Editorial correspondence

Wolverine Meds is an editorial project covering the BPC-157 TB-500 research record. Use the form below for corrections to a citation, questions about a summary, or notes on the published literature. We read every message about the accuracy of what we publish.

We cannot help with anything clinical or commercial. We do not provide medical advice, dosing guidance, or treatment recommendations; we are not a clinic and employ no clinicians. We do not sell, supply, source, or price any peptide, and we cannot point you to anywhere that does. Questions about obtaining the blend are outside what this editorial project does — the access page explains the general regulatory framework instead.

## Send a message

Use the form to reach the editorial desk. Include the page and the citation number you are writing about so we can check it against the source quickly. We aim to correct any genuine error in the record promptly.

---

Two peptide channels read on one console — BPC-157 and TB-500 traced to their own studies and their own 503A status, every blend-level gap left lit, with no clinic at the terminal and nothing here to dispense.